To Get Help Now
Click Here
Today's Date:

First TVT-Abbrevo Trial Ends in $5.7 Verdict for the Plaintiff

AddThis Social Bookmark Button

First TVT-Abbrevo Trial Ends in $5.7 Verdict for Plaintiff

First TVT-Abbrevo Trial Ends in $5.7 Verdict for Plaintiff

A Bakersfield, California, jury awarded $5.7 million on Thursday to a woman who alleged she was implanted with a defective TVT-Abbrevo pelvic mesh sling made by Ethicon, a subsidiary of Johnson  & Johnson (J&J). It was the first trial centered on the device.

The TVT-Abbrevo device is intended for the treatment of urinary incontinence caused by sudden movements. The plaintiff in the case, who had the device implanted in 2011, alleged that her TVT-Abbrevo caused her pain and continued urinary incontinence, according to The National Law Journal (The Journal).

The jury agreed with the plaintiff that the TVT-Abbrevo device was defectively designed and that Ethicon had failed to warn doctors about the problems associated with it and awarded the woman $700,000 in compensatory damages and $5 million in punitive damages. J&J said the company plans to appeal the decision, The Journal reported.

“We have strong grounds for appeal as we believe the evidence showed that TVT Abbrevo midurethral sling was properly designed and Ethicon acted appropriately and responsibly in the research, development and marketing of the product,” Ethicon spokesman Matthew Johnson said. “TVT Abbrevo has been deemed safe and effective by regulators and practitioners alike.”

There are currently seven pelvic mesh manufacturers being sued over their pelvic mesh products. On September 5, 2014, a Charleston, West Virginia, jury hit Ethicon with a $3.27 million verdict in what was the first trial in that docket, according to The Journal. disclaimer: This article: First TVT-Abbrevo Trial Ends in $5.7 Verdict for the Plaintiff was posted on Monday, March 9th, 2015 at 4:22 pm at and is filed under Construction Defect Lawsuits, Medical Device Lawsuits.

« »

Comments are closed.